US

Joffre B Baker

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joffre B Baker. Retrieved from https://idiyas.com/inventor/joffre-b-baker-hamzwxbo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Joffre B Baker: Innovator in Protease Research

Introduction

Joffre B Baker is a notable inventor based in the United States. He has made significant contributions to the field of protease research, particularly in the development of recombinant proteins. Although he holds no patents, his work has been influential in advancing diagnostic and therapeutic applications.

Latest Patents

Baker's latest work includes the invention of Recombinant Purified Protease Nexin. This involves DNA segments encoding two slightly different forms of protease nexin I, specifically PN-I.alpha. and PN-I.beta. These segments are cloned and expressed to provide practical quantities of PN-I for diagnostic and therapeutic use. PN-I serves as a serine protease inhibitor, which is useful in controlling conditions mediated by proteolytic activity.

Career Highlights

Throughout his career, Joffre B Baker has worked with various companies, including Michael P. McGrogan and Randy W. Scott. His collaborations have allowed him to contribute to significant advancements in the field of protease inhibitors.

Collaborations

Baker has collaborated with notable individuals such as Michael P. McGrogan and Randy W. Scott. Their combined expertise has fostered innovation in protease research.

Conclusion

Joffre B Baker's work in recombinant protease research highlights his commitment to advancing medical science. His contributions, although not patented, have the potential to impact therapeutic practices significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…